SEC Form 4 · accession 0001179110-17-014210
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Gesua Sive Salvadori
Officer — Executive Vice President
Period of report
Nov 14, 2017
Accepted (ET)
Nov 16, 2017 · 5:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Nov 14, 2017 | M | 71,157 | $38.40 | A | 144,955 | D | |
| Common shares without par value | Nov 14, 2017 | S | 71,157 | $55.00 | D | 73,798 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F1 | $38.40 | Nov 14, 2017 | M | 71,157 | D | Feb 19, 2017 | Feb 18, 2026 | Common shares | 71,157 | 142,313 | D |
Explanation of responses
- F1Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
Remarks
These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).